Celebrating a Milestone: Cellex's 25th Year Highlighting Advances in Cell and Gene Therapy

On November 8, 2026, Cologne witnessed a significant gathering of more than 100 professionals at the Cellex Symposium 2026, marking the 25th anniversary of Cellex Cell Professionals. Hosted in the historic Wasserturm Hotel, the event was themed "Cell and Gene Therapy at a Turning Point," showcasing the rapid advancements in this crucial field. The symposium featured ten scientific presentations divided into three sessions, encompassing the entire journey from research and development to global marketing of innovative therapies.

The first session, titled "Translation From Cells to Clinical Impact," focused on the practical implementation of cell therapies in clinical settings. Esteemed speakers, including Dr. Hyatt Balke-Want from the University Hospital Cologne, Dr. Jens Altrichter from Artcline GmbH, and Dr. Matthias Domogalla from Cellex, explored topics such as genetically modified T-cells and the role of GMP compliance as a driving factor for production performance. Their insights shed light on the critical transition from laboratory research to real-world application, essential for the future of medicine.

The second session, themed "Targeting," aimed to address challenges posed by hard-to-treat cancers and genetic disorders. This segment featured talks on topics ranging from peptide vaccines to gene-editing platforms, including advances in TCR-T cells specific to PRAME and the targeting of difficult antigens in both solid tumors and hematological malignancies. Noteworthy speakers such as Prof. Elke Jäger from Krankenhaus Nordwest Frankfurt and Prof. Martin Wermke from the University Hospital Dresden provided invaluable insights into these complex issues, highlighting the urgent need for innovative solutions in oncological therapies.

In addition to the presentations, the symposium fostered discussions on artificial intelligence in regulated environments and maintaining product quality across various production sites during moderated expert tables. This aspect of the event emphasized the importance of collaboration and knowledge sharing among industry leaders to improve therapeutic outcomes.

The final session, "Market Reality," delved into the practicalities of scaling cell and gene therapies. Key issues discussed included the nature of GMP raw materials, integrated CDMO models, and China's rising role in global biotechnology. Industry experts such as Rachel Atlee from Akron Bio and Dr. Suvi Annala from Cellex addressed these essentials, articulating visions for efficient production strategies that will enable widespread access to advanced therapies.

Reflecting on the event, Prof. Dr. med. Martin Wermke noted, "It was a fantastic opportunity to reconnect with friends and colleagues in the cell and gene therapy field. The symposium efficiently covered the entire process from research and development to commercialization in just one day. The open exchange between academia and industry highlighted that the decisions we make now will shape the next decade of our field."

Dr. Armin Ehninger, scientific and strategic leader at Cellex, echoed these sentiments, remarking, "Advanced therapies will only reach patients at scale when science, manufacturing, and regulatory expertise move forward in tandem. This symposium united these diverse perspectives, and we look forward to continuing these discussions with our partners."

Founded 25 years ago with a focus on stem cell donor registries through apheresis services, Cellex has evolved into a leading CDMO for cell therapies. With over a decade of experience in manufacturing both autologous and allogeneic products, the organization is well-equipped to support partners in pharmaceutical, biotechnology, and scientific sectors throughout preclinical and clinical development stages, as well as in commercial production. Cellex combines GMP manufacturing expertise with capabilities in cellular raw material collection and supply chain management, establishing a robust foundation for future innovations in the therapeutic landscape. For more information, visit Cellex's website.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.